Motorika Nemo LLC received perpetual registration certificates for medical devices included in the vagus nerve stimulation system manufactured by Rishena. These devices target drug-resistant epilepsy, a condition that impacts 20-30% of the approximately 50 million individuals living with epilepsy globally.
Rishena Medical is a pioneering Chinese company dedicated to scientific research and development, specializing in the manufacturing and sales of active implantable medical devices. To date, Rishena Medical has registered more than 100 patents and continues to develop new devices. Motorika Nemo LLC is set to launch the VNS201B implantable device for vagus nerve stimulation, along with its accompanying implantable electrode and programmers, in the domestic market.
